These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23599070)

  • 1. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
    Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
    Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?
    Tsou YA; Hua JH; Lin MH; Tsai MH
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):206-12. PubMed ID: 16508339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
    Preuss SF; Dinh V; Klussmann JP; Semrau R; Mueller RP; Guntinas-Lichius O
    Oral Oncol; 2007 Apr; 43(4):402-7. PubMed ID: 17071133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the "violated neck" in the era of chemoradiation.
    Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
    Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid predictors of poor response to chemoradiotherapy for laryngeal squamous cell carcinoma.
    Hu M; Ampil F; Clark C; Sonavane K; Caldito G; Nathan CA
    Laryngoscope; 2012 Mar; 122(3):565-71. PubMed ID: 22252981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment.
    Denittis AS; Machtay M; Rosenthal DI; Sanfilippo NJ; Lee JH; Goldfeder S; Chalian AA; Weinstein GS; Weber RS
    Am J Otolaryngol; 2001; 22(5):329-35. PubMed ID: 11562884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
    White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
    Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
    Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.
    Lee WM; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Ryu SY
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):219-23. PubMed ID: 22326616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal carcinoma in young adults: an alarming national trend.
    Gayar OH; Ruterbusch JJ; Elshaikh M; Cote M; Ghanem T; Hall F; Siddiqui F
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):594-601. PubMed ID: 24452304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
    Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
    Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.
    Mullen JT; Rodriguez-Bigas MA; Chang GJ; Barcenas CH; Crane CH; Skibber JM; Feig BW
    Ann Surg Oncol; 2007 Feb; 14(2):478-83. PubMed ID: 17103253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
    Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of presentation-to-diagnosis interval in patients with oropharyngeal carcinoma.
    Ho T; Zahurak M; Koch WM
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):45-51. PubMed ID: 14732767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.